Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Athanasios Markopoulos, Antonio Inserra, Danilo De Gregorio, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
Natacha Perez, Florent Langlest, Luc Mallet, et al.
European Neuropsychopharmacology (2023) Vol. 76, pp. 61-76
Open Access | Times Cited: 41
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
Danilo De Gregorio, Antonio Inserra, Justine P. Enns, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1188-1198
Open Access | Times Cited: 60
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 36
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling
Antonio Inserra, Antonella Campanale, David Cheishvili, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110594-110594
Closed Access | Times Cited: 27
A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond
Marco Pepe, Mohsen Hesami, Karla A. de la Cerda, et al.
Biotechnology Advances (2023) Vol. 69, pp. 108247-108247
Closed Access | Times Cited: 14
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
Nadine Loh, David Luke
Psychoactives (2025) Vol. 4, Iss. 1, pp. 7-7
Open Access
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome
Antonio Inserra, Giada Giorgini, Sébastien Lacroix, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 6, pp. 721-739
Closed Access | Times Cited: 17
Deep CANALs: A Deep Learning Approach to Refining the Canalization Theory of Psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
(2023)
Open Access | Times Cited: 9
Social identity processes as a vehicle for therapeutic success in psychedelic treatment
Martha Newson, S. Alexander Haslam, Catherine Haslam, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1010-1017
Closed Access | Times Cited: 3
Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome
Valeria Buzzelli, Emilia Carbone, Antonia Manduca, et al.
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 137-147
Closed Access | Times Cited: 15
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review
James J Gattuso, Carey Wilson, Anthony J. Hannan, et al.
Journal of Neurochemistry (2023)
Open Access | Times Cited: 8
Cognición extendida y símbolos de la velada mazateca con hongos psilocibios
Seraid Caynas-Rojas, Roberto E. Mercadillo
Andamios (2024) Vol. 21, Iss. 54, pp. 179-210
Open Access | Times Cited: 2
Autism, youth suicide, and psychedelics: A review of the 21st century evidence
Mu-Hong Chen, Tung-Ping Su, Ju‐Wei Hsu, et al.
Journal of the Chinese Medical Association (2024) Vol. 87, Iss. 10, pp. 904-911
Open Access | Times Cited: 2
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges
Mauro Scala, Chiara Fabbri, Paolo Fusar‐Poli, et al.
CNS Spectrums (2024), pp. 1-15
Closed Access | Times Cited: 2
Psychedelic Mystical Experience: A New Agenda for Theology
Ron Cole‐Turner
Religions (2022) Vol. 13, Iss. 5, pp. 385-385
Open Access | Times Cited: 11
Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions
Salam Salloum‐Asfar, Nasser Zawia, Sara Abdulla
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108564-108564
Open Access | Times Cited: 6
Uncovering Structure–Activity Relationships of Phenethylamines: Paving the Way for Innovative Mental Health Treatments
Sedat Karabulut, Harpreet Kaur, James W. Gauld
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 5, pp. 972-982
Closed Access | Times Cited: 1
The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies
Zhen Xuen Brandon Low, Wei Shen Ng, Eugene Lim, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024), pp. 111139-111139
Open Access | Times Cited: 1
Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey
Jack Stroud, Charlotte Rice, A Orsini, et al.
Psychopharmacology (2024)
Closed Access | Times Cited: 1
The Many Faces of Psilocybin-Related Psychosis: A Case Series
Y J Kim, Rachel Bigley, Aubrey DeVinney, et al.
Psychiatry Research Case Reports (2024) Vol. 4, Iss. 1, pp. 100243-100243
Open Access | Times Cited: 1
Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography–Tandem Mass Spectrometry Methods
Alexandra Dimitrova, Maria Grazia Di Milia, Regina Rensi, et al.
Separations (2023) Vol. 10, Iss. 9, pp. 502-502
Open Access | Times Cited: 3
The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors
Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 10, pp. 1480-1491
Open Access | Times Cited: 3
Exercise in the Treatment of Repetitive, Self-Injurious, and Aggressive Behavior in Adults with Autism Spectrum Disorder: A Neurobiological Analysis
Im DS
Journal of Neurology and Neurobiology (2024) Vol. 9, Iss. 1
Open Access
Medical Use of Cannabinoids and Psychedelic Compounds
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Springer eBooks (2024), pp. 4415-4443
Closed Access
Page 1 - Next Page

Scroll to top